These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19190977)
21. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500 [TBL] [Abstract][Full Text] [Related]
22. Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an Intensive Care Unit: a case report. Saito T; Shime N; Itoh K; Fujita N; Saito Y; Shinozaki M; Shibuya K; Makimura K; Hashimoto S Infection; 2009 Dec; 37(6):547-50. PubMed ID: 19730788 [TBL] [Abstract][Full Text] [Related]
24. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Han WK; Choi HK; Roth RM; McCluskey RT; Niles JL Kidney Int; 2003 Mar; 63(3):1079-85. PubMed ID: 12631091 [TBL] [Abstract][Full Text] [Related]
25. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Hogan SL; Falk RJ; Chin H; Cai J; Jennette CE; Jennette JC; Nachman PH Ann Intern Med; 2005 Nov; 143(9):621-31. PubMed ID: 16263884 [TBL] [Abstract][Full Text] [Related]
26. Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission. Muto R; Inagaki K; Sato N; Sameshima T; Nagakura Y; Baba S; Kato N; Maruyama S; Akahori T Intern Med; 2020 Dec; 59(24):3187-3193. PubMed ID: 32788533 [TBL] [Abstract][Full Text] [Related]
27. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse. Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560 [TBL] [Abstract][Full Text] [Related]
28. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. Bosch X; Guilabert A; Espinosa G; Mirapeix E JAMA; 2007 Aug; 298(6):655-69. PubMed ID: 17684188 [TBL] [Abstract][Full Text] [Related]
30. Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis. de Joode AA; Roozendaal C; van der Leij MJ; Bungener LB; Sanders JS; Stegeman CA Eur J Intern Med; 2014 Feb; 25(2):182-6. PubMed ID: 24361117 [TBL] [Abstract][Full Text] [Related]
31. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study. Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic potential of antibody titres against Candida cell wall β-glucan in Kawasaki disease. Ishibashi K; Fukazawa R; Miura NN; Adachi Y; Ogawa S; Ohno N Clin Exp Immunol; 2014 Jul; 177(1):161-7. PubMed ID: 24635107 [TBL] [Abstract][Full Text] [Related]
33. Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3. Fussner LA; Hummel AM; Schroeder DR; Silva F; Cartin-Ceba R; Snyder MR; Hoffman GS; Kallenberg CG; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; William St Clair E; Tchao NK; Stone JH; Specks U; Arthritis Rheumatol; 2016 Jul; 68(7):1700-10. PubMed ID: 26882078 [TBL] [Abstract][Full Text] [Related]
34. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy? Mandl LA; Solomon DH; Smith EL; Lew RA; Katz JN; Shmerling RH Arch Intern Med; 2002 Jul; 162(13):1509-14. PubMed ID: 12090888 [TBL] [Abstract][Full Text] [Related]
35. [Diagnosis und therapy of ANCA-associated vasculitis]. Aries PM; Hellmich B; Gross WL Dtsch Med Wochenschr; 2006 Mar; 131(9):443-6. PubMed ID: 16493569 [TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis. de Groot K; Goldberg C; Bahlmann FH; Woywodt A; Haller H; Fliser D; Haubitz M Arthritis Rheum; 2007 Nov; 56(11):3847-53. PubMed ID: 17968939 [TBL] [Abstract][Full Text] [Related]
37. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845 [TBL] [Abstract][Full Text] [Related]
38. Persistent hematuria in patients with antineutrophil cytoplasmic antibody-associated vasculitis during clinical remission: chronic glomerular lesion or low-grade active renal vasculitis? Lv L; Chang DY; Li ZY; Chen M; Hu Z; Zhao MH BMC Nephrol; 2017 Dec; 18(1):354. PubMed ID: 29207950 [TBL] [Abstract][Full Text] [Related]
39. Usefulness of tissue inhibitor of metalloproteinase 1 as a predictor of sustained remission in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Ishizaki J; Takemori A; Horie K; Hiraoka D; Suemori K; Matsumoto T; Sada KE; Amano K; Harigai M; Arimura Y; Makino H; Takenaka K; Takemori N; Hasegawa H; Arthritis Res Ther; 2021 Mar; 23(1):91. PubMed ID: 33743769 [TBL] [Abstract][Full Text] [Related]
40. Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study. Yang L; Xie H; Liu Z; Chen Y; Wang J; Zhang H; Ge Y; Hu W BMC Nephrol; 2018 Jun; 19(1):138. PubMed ID: 29902982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]